Opportunity Information: Apply for PA 18 932
Increasing Uptake of Evidence-Based Screening in Diverse Adult Populations (R01 Clinical Trial Optional) is a National Institutes of Health (NIH) grant opportunity that supports research aimed at reducing disparities in the use of proven screening services across the adult lifespan. The focus is on evidence-based screening, meaning screening recommendations that have been shown to be effective through rigorous scientific review by authoritative bodies. In this announcement, "screening" is specifically defined as a preventive service intended to detect an undiagnosed disease in people who do not yet have symptoms, distinguishing it from diagnostic testing that occurs after symptoms appear.
The core purpose of the opportunity is to generate practical, research-backed strategies that increase screening uptake among diverse adult populations and help close gaps tied to race, ethnicity, geography, socioeconomic status, disability, language, and other factors that can influence access and participation. Projects are expected to strengthen the overall screening process by studying how screening can be improved or delivered more effectively in three broad areas: first, within diverse populations; second, across a range of clinical and community settings (for example, primary care clinics, federally qualified health centers, pharmacies, workplaces, faith-based settings, community organizations, or mobile/community-based programs); and third, through different types of providers, including traditional clinicians as well as non-traditional and allied health providers who may be important for outreach, navigation, education, and screening delivery.
This is an R01 mechanism, which generally supports substantial, hypothesis-driven research programs, and the notice indicates that clinical trials are optional. That means applicants may propose studies that involve clinical trial designs when appropriate, but they can also propose non-trial research approaches such as implementation science studies, pragmatic evaluations, or multi-level intervention research, as long as the work is tightly aligned with improving uptake of evidence-based screening and addressing disparities. The underlying expectation is that funded research will produce actionable knowledge about what works, for whom, and in what settings, rather than simply describing disparities.
Eligibility is broad and includes many kinds of U.S.-based organizations and governmental entities. Eligible applicants include state, county, and city or township governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; Native American tribal governments (federally recognized); tribal organizations that are not federally recognized; public housing authorities and Indian housing authorities; nonprofits with and without 501(c)(3) status (excluding higher education institutions in those nonprofit categories); for-profit organizations other than small businesses; and small businesses. The announcement also highlights additional eligible applicant types such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISISs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based and community-based organizations, eligible federal government agencies, regional organizations, tribal governments other than federally recognized ones, and U.S. territories or possessions. At the same time, the opportunity clearly restricts foreign involvement: non-U.S. entities are not eligible to apply, non-U.S. components of U.S. organizations are not eligible, and foreign components (as defined by NIH policy) are not allowed under this FOA.
Administratively, the program is listed as a discretionary grant with activity categories in education and health, and it is associated with multiple CFDA numbers (93.121, 93.242, 93.273, 93.279, 93.307, 93.399, 93.866), reflecting NIH program areas that can intersect with preventive services and population health. The funding opportunity number is PA 18 932, with a creation date of September 21, 2018, and an original closing date shown as May 7, 2022. No award ceiling or expected number of awards is provided in the summary information shown, which typically means applicants need to rely on the full FOA and NIH institute guidance for budgeting expectations and likely award patterns.
Overall, this opportunity is designed for applicants who can rigorously test or evaluate strategies that make evidence-based screening more equitable in real-world conditions, especially by working across health care and community systems and by engaging the full range of professionals and trusted organizations that influence whether adults actually get screened.Apply for PA 18 932
- The National Institutes of Health in the education, health sector is offering a public funding opportunity titled "Increasing Uptake of Evidence-Based Screening in Diverse Adult Populations (R01 Clinical Trial Optional)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.121, 93.242, 93.273, 93.279, 93.307, 93.399, 93.866.
- This funding opportunity was created on 2018-09-21.
- Applicants must submit their applications by 2022-05-07. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Browse more opportunities from the same category: Education, Health
Next opportunity: Alzheimer's Disease Research Centers (P30 Clinical Trial Not Allowed)
Previous opportunity: BRAIN Initiative: Development of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in Human and Non-Human Primate Brain (UG3/UH3 Clinical Trial Optional)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PA 18 932
Applicants also applied for:
Applicants who have applied for this opportunity (PA 18 932) also looked into and applied for these:
| Funding Opportunity |
|---|
| Administrative Supplements to Cancer Center Support Grants to Strengthen NCI-Supported Community Outreach Capacity through Community Health Educators of the National Outreach Network (Admin Suppl - Clinical Trial Not Allowed) Apply for PAR 18 931 Funding Number: PAR 18 931 Agency: National Institutes of Health Category: Education, Health Funding Amount: $125,000 |
| Integrating Biospecimen Science Approaches into Clinical Assay Development (U01 Clinical Trial Not Allowed) Apply for PAR 18 947 Funding Number: PAR 18 947 Agency: National Institutes of Health Category: Education, Health Funding Amount: $250,000 |
| Biobehavioral Basis of Chronic Pain (R21 Clinical Trial Optional) Apply for PA 18 943 Funding Number: PA 18 943 Agency: National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
| Biobehavioral Basis of Chronic Pain (R01 Clinical Trial Optional) Apply for PA 18 944 Funding Number: PA 18 944 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Applying a Biopsychosocial Perspective to Self-Management of Chronic Pain (R21 Clinical Trial Optional) Apply for PA 18 946 Funding Number: PA 18 946 Agency: National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
| Applying a Biopsychosocial Perspective to Self-Management of Chronic Pain (R01 Clinical Trial Optional) Apply for PA 18 945 Funding Number: PA 18 945 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Mechanisms of Disparities in Etiology and Outcomes of Lung Cancer in the U.S.: The Role of Risk and Protective Factors (R21 Clinical Trial Not Allowed) Apply for PAR 19 019 Funding Number: PAR 19 019 Agency: National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
| Mechanisms of Disparities in Etiology and Outcomes of Lung Cancer in the U.S.: The Role of Risk and Protective Factors (R01 Clinical Trial Not Allowed) Apply for PAR 19 018 Funding Number: PAR 19 018 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Addressing Caregiver Symptoms through Technological Tools (R01 Clinical Trial Optional) Apply for PA 19 023 Funding Number: PA 19 023 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Addressing Caregiver Symptoms through Technological Tools (R21 Clinical Trial Optional) Apply for PA 19 024 Funding Number: PA 19 024 Agency: National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
| Commercializing Understudied Proteins from the Illuminating the Druggable Genome Project (IDG) (R43/R44 Clinical Trial Not Allowed) Apply for PA 19 034 Funding Number: PA 19 034 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Commercializing Understudied Proteins from the Illuminating the Druggable Genome Project (IDG) (R41/R42 Clinical Trial Not Allowed) Apply for PA 19 033 Funding Number: PA 19 033 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Promoting Research on Music and Health: Fundamentals and Applications (R01 Clinical Trials Optional) Apply for RFA NS 19 008 Funding Number: RFA NS 19 008 Agency: National Institutes of Health Category: Education, Health Funding Amount: $250,000 |
| End-of-Life and Palliative Care Approaches to Advanced Signs and Symptoms (R01 Clinical Trial Optional) Apply for PAR 19 045 Funding Number: PAR 19 045 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| End-of-Life and Palliative Care Approaches to Advanced Signs and Symptoms (R21- Clinical Trial Optional) Apply for PAR 19 044 Funding Number: PAR 19 044 Agency: National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
| Accelerating Colorectal Cancer Screening and follow-up through Implementation Science (ACCSIS)(UG3/UH3 Clinical Trial Required) Apply for RFA CA 19 018 Funding Number: RFA CA 19 018 Agency: National Institutes of Health Category: Education, Health Funding Amount: $500,000 |
| Strategies to Provide Culturally Tailored Palliative and End-of-Life Care for Seriously Ill American Indian and Alaska Native Individuals (R21 Clinical Trial Optional) Apply for PAR 19 058 Funding Number: PAR 19 058 Agency: National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
| Strategies to Provide Culturally Tailored Palliative and End-of-Life Care for Seriously Ill American Indian and Alaska Native Individuals (R01 Clinical Trial Optional) Apply for PAR 19 057 Funding Number: PAR 19 057 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| NINR Clinical Trial Planning Grant (R34 Clinical Trial Required) Apply for PAR 19 060 Funding Number: PAR 19 060 Agency: National Institutes of Health Category: Education, Health Funding Amount: $150,000 |
| Mechanism for Time-Sensitive Drug Abuse Research (R21 Clinical Trial Optional) Apply for PAR 19 064 Funding Number: PAR 19 064 Agency: National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PA 18 932", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.